Role of preoperative gonadotropin-releasing hormone agonist in post-operative adhesion formation after myomectomy.

被引：2
|
作者：
Coddington, CC
Grow, DR
Ahmed, MS
Brown, SE
Toner, JP
Diamond, M
机构：
[1] Eastern Virginia Med Sch, Clin Res Ctr, Norfolk, VA 23501 USA
[2] Baystate Med Ctr, Dept Obstet & Gynecol, Springfield, MA USA
[3] Atlanta Ctr Reprod Med, Woodstock, GA USA
[4] Wayne State Univ, Detroit, MI 48202 USA
来源：
FERTILITY AND STERILITY | 2005年 / 84卷
关键词：
D O I：
10.1016/j.fertnstert.2005.07.1220
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S465 / S466
页数：2
相关论文
共 50 条
  • [21] The efficacy of gonadotropin-releasing hormone agonist treatment before hysteroscopic myomectomy for large-sized submucosal leiomyoma
    Park, Mia
    Song, Min Soon
    Kang, Byung Hun
    Song, Soo Youn
    Lee, Geon Woo
    Jung, Ye Won
    Shin, Won Kyo
    Ko, Young Bok
    Lee, Ki Hwan
    Yoo, Heon Jong
    [J]. MEDICINE, 2022, 101 (31) : E29726
  • [22] EQUIVALENCY OF HUMAN MENOPAUSAL GONADOTROPIN AND FOLLICLE-STIMULATING-HORMONE STIMULATION AFTER GONADOTROPIN-RELEASING HORMONE AGONIST SUPPRESSION
    EDELSTEIN, MC
    BRZYSKI, RG
    JONES, GS
    SIMONETTI, S
    MUASHER, SJ
    [J]. FERTILITY AND STERILITY, 1990, 53 (01) : 103 - 106
  • [23] Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist
    Yu, KJ
    Lai, CR
    Sheu, MH
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 96 (02): : 223 - 225
  • [24] Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest
    Matsushima, Takashi
    Akira, Shigeo
    Yoneyama, Koichi
    Takeshita, Toshiyuki
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (06) : 521 - 524
  • [25] Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer
    Smith, MR
    Boyce, SP
    Moyneur, E
    Duh, MS
    Raut, MK
    Brandman, J
    [J]. JOURNAL OF UROLOGY, 2006, 175 (01): : 136 - 139
  • [26] PITUITARY AND OVARIAN SUPPRESSION RATE AFTER HIGH DOSAGE OF GONADOTROPIN-RELEASING HORMONE AGONIST
    BIDER, D
    GOLDENBERG, M
    BENRAFAEL, Z
    MASHIACH, S
    SHALEV, J
    BLANKSTEIN, J
    [J]. FERTILITY AND STERILITY, 1989, 51 (04) : 578 - 581
  • [27] Testicular development of Zebu bulls after chronic treatment with a gonadotropin-releasing hormone agonist
    Jiménez-Severiano, H
    Mussard, ML
    Fitzpatrick, LA
    D'Occhio, MJ
    Ford, JJ
    Lunstra, DD
    Kinder, JE
    [J]. JOURNAL OF ANIMAL SCIENCE, 2005, 83 (09) : 2111 - 2122
  • [28] Thyroid Dysfunction after Gonadotropin-Releasing Hormone Agonist Administration in Women with Thyroid Autoimmunity
    Marin, Loris
    Ambrosini, Guido
    Noventa, Marco
    Filippi, Flavia
    Ragazzi, Eugenio
    Dessole, Francesco
    Capobianco, Giampiero
    Andrisani, Alessandra
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 2022
  • [29] Successful pregnancy after gonadotropin-releasing hormone analogue and hysteroscopic myomectomy in a woman with diffuse uterine leiomyomatosis
    Yoshihiko Shimizu
    Hiroko Yomo
    Nobuyuki Kita
    Kentaro Takahashi
    [J]. Archives of Gynecology and Obstetrics, 2009, 280 : 145 - 147
  • [30] Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas
    Ozaki, Rie
    Kumakiri, Jun
    Jinushi, Makoto
    Ikuma, Shinichiro
    Murakami, Keisuke
    Kawasaki, Yu
    Kitade, Mari
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (04) : 969 - 976
12345